KSE - Delayed Quote • KRW
Samil Pharmaceutical Co.,Ltd (000520.KS)
As of 11:14 AM GMT+9. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Kang Huh | Chief Executive Officer | -- | -- | 1953 |
Boo-Hwan Ko | President | -- | -- | 1955 |
Samil Pharmaceutical Co.,Ltd
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
Corporate Governance
Samil Pharmaceutical Co.,Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Dec 29, 2021Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available